Development and characterization of dutasteride bearing liposomal systems for topical use

Current Drug Discovery Technologies

Volumn 8, Issue 2, 2011, Pages 136-145

  Sharma, Purushottam ^a   Jain, Deepika ^a   Maithani, Mukesh ^a   Mishra, Santosh Kumar ^a   Khare, Piush ^a   Jain, Vikas ^a   Singh, Ranjit ^a  

^a SHOBHIT UNIVERSITY   (India)

Author keywords

Alopecia; Hydrogel; Liposome; Multilamellar vesicles; Skin deposition; Suspension

Indexed keywords

CHOLESTEROL; DUTASTERIDE; PHOSPHATIDYLCHOLINE;

ANIMAL TISSUE; ARTICLE; DRUG FORMULATION; DRUG STABILITY; LIPOSOMAL DELIVERY; MALE TYPE ALOPECIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN PERMEABILITY;

5-ALPHA REDUCTASE INHIBITORS; ADMINISTRATION, CUTANEOUS; ALCOHOLS; ANIMALS; AZASTEROIDS; CHEMISTRY, PHARMACEUTICAL; CHOLESTEROL; COLD TEMPERATURE; DRUG COMPOUNDING; DRUG STABILITY; GELS; LIPOSOMES; MICE; PARTICLE SIZE; PERMEABILITY; PHOSPHATIDYLCHOLINES; SKIN; SKIN ABSORPTION; SONICATION; TECHNOLOGY, PHARMACEUTICAL;

EID: 79956147510     PISSN: 15701638     EISSN: 18756220     Source Type: Journal    
DOI: 10.2174/157016311795563901     Document Type: Article

References (37)

1. Kaufman KD. Androgens and alopecia. Molecular and cellular endocrinology 2002; 198: 89-95. (Pubitemid 36169938)
2. Ellis JA, Sinclair RD. Male pattern baldness: current treatments, future prospects. Drug Discov Today 2008; 13(17/18): 791-7.
3. Tabbakhian M, Tavakoli N, Jaafari MR, Daneshamouz S. Enhancement of follicular delivery of finasteride by liposomes and niosomes: In vitro permeation and in vivo deposition studies using hamster flank and ear models. Int J Pharm 2006; 323: 1-10. (Pubitemid 44397357)
4. Sarker DK. Sculpted amphiphilic liposomal particles for modifiable medicinal applications. Curr Drug Discov Technol 2009; 6: 52-58.
5. Kumar R, Singh B, Bakshi G, Katare OP. Development of liposomal systems of finasteride for topical applications: Design, characterization, and in vitro evaluation. Pharm Dev Technol 2007; 12: 591-601.
6. Lauer AC, Ramachandran C, Lieb LM, Niemiec S, Weiner ND. Targeted delivery to the pilosebaceous unit via liposomes. Advanced Drug Deliv Rev 1996; 18: 311-324. (Pubitemid 26062291)
7. Müller RH, Shegokar R, Keck CM. 20 Years of Lipid Nanoparticles (SLN & NLC): Present State of Development & Industrial Applications. Curr Drug Discov Technol 2011 Feb 4 [Epub ahead of print].
8. Fielding MR. Liposomal drug delivery: advantages and limitations from a clinical pharmacokinetics and therapeutic perpective. Clin Pharmacokinet 1991; 21: 155-64.
9. Gregoriadis G. Overview of liposomes. J Antimicrob Chemother 1991; 28(supp. B): 39-48.
10. Xian-rong Q, Yoshie M, Tsuneji N. Effect of soybean-derived sterols on the in vitro stability and the blood circulation of liposomes in mice. Int J Pharm 1995; 114: 33-41.
11. Sajja HK, East MP, Mao H, Wang YA, Nie S, Yang L. Development of multifunctional nanoparticles for targeted drug delivery and noninvasive imaging of therapeutic effect. Curr Drug Discov Technol 2009; 6: 43-51.
12. Schreier H, Bouwstra JA. Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery. J Contr Rel 1994; 30: 1-15. (Pubitemid 24173173)
13. Kamat SS, Choudhari VB, Vele VT, Prabhune SS. Determination of dutasteride by LC: Validation and application of the method. Chromatographia 2008; 67(11-12): 911-6.
14. Agarwal R, Katare OP, Vyas SP. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int J Pharm 2001; 228: 43-52. (Pubitemid 32905364)
15. Nasr M, Mansour S, Mortada ND, Elshamy AA. Vesicular aceclofenac systems: A comparative study between liposomes and nosomes. J Microencapsul 2008; 25(7): 499-512.
16. Carrara DNR, Grenier A. Pharmaceutical compositions of 5α- reductase inhibitors and methods of use thereof. United States Patent 2009/0069364 A1.
17. Morilla MJ, Benavidez P, Lopez MO, Bakas L, Romero EL. Development and in-vitro characterization of a benznidazole liposomal formulation. Int J Pharm 2002; 249: 89-99. (Pubitemid 35333435)
18. Luigi L, Santarelli MF, Landini L, Positano V. Ultrasound techniques for drug delivery in cardiovascular medicine. Curr Drug Discov Technol 2008; 5: 328-332.
19. Jain SK, Singh R, Sahu B. Development of a liposome based contraceptive system for intravaginal administration of progesterone. Drug Dev Ind Pharm 1997; 23(8): 827-830. (Pubitemid 27325710)
20. New RRC. Liposomes: A practical approach, IRL Press. 1990; Oxford.
21. Betz G, Aeppli A, Menshutina N, Leuenberger H. In-vivo comparison of various liposome formulations for cosmetic application. Int J Pharm 2005; 296: 44-54. (Pubitemid 40693371)
22. Gupta PN, Mishra V, Rawat A, et al. Non-invasive vaccine delivery in transferosomes, niosomes and liposomes: a comparative study. Int J Pharm 2005; 293: 73-82. (Pubitemid 40381082)
23. Plessis J, Ramchandran C, Weiner N, Muller DG. The influence of lipid composition and lamellarity of liposomes on the physical stability of liposomes upon storage. Int J Pharm 1996; 127: 273-8. (Pubitemid 26091011)
24. Trotta M, Peira E, Carlotti ME, Gallarate M. Deformable liposomes for dermal administration of methotrexate. Int J Pharm 2004; 270: 119-25. (Pubitemid 38077093)
25. Patel VB, Mishra AN. Encapsulation and stability of clofazimine liposomes. J Microencaps 1999; 16: 357-67. (Pubitemid 29191818)
26. Manosroi A, Podjanasoonthon K, Manosroi J. Development of novel topical tranexamic acid liposome formulation. Int J Pharm 2002; 235: 61-70. (Pubitemid 34185437)
27. Nasseri B. Effect of cholesterol and temperature on the elastic properties of niosomal membranes. Int J Pharm 2005; 300: 95-101. (Pubitemid 41112171)
28. Friedman DI, Schwarz JS, Weisspapir M. Submicron emulsion vehicle for enhanced transdermal delivery of steroidal and nonsteroidal anti-inflammatory drugs. J Pharm Sci 1995; 84: 324-9.
29. Zeisig R, Shimada K, Hirota S, Arndt D. Effect of sterical stabilization on macrophage uptake in vitro and on thickness of the fixed aqueous layer of liposomes made from alkylphosphocholines. Biochim Biophys Acta Biomembranes 1996; 1285: 237-45. (Pubitemid 26403082)
30. Yarosh DB. Liposomes in investigative dermatology. Photodermatol Photoimmunol Photomed 2001; 17: 203-12. (Pubitemid 32834284)
31. Singh B, Mehta G, Kumar R, Bhatia A, Ahuja N, Katare OP. Design, development and optimization of nimesulide-loaded liposomal systems for topical application. Curr Drug Deliv 2005; 2: 143-53. (Pubitemid 40488624)
32. Valenta C, Wanka M, Heidlas J. Evaluation of a novel soyalecithin formulation for dermal use containing ketoprofen as a model drug. J Control Release 2000; 63: 165-73. (Pubitemid 30046952)
33. Ogiso T, Niinaka N, Iwaki M. Mechanism for enhancement effect of lipid disperse system on percutaneous absorption. J Pharm Sci 1996; 85: 57-64. (Pubitemid 26029626)
34. Dreher F, Walde P, Walther P, Wehrli E. Interaction of a lecithin microemulsion gel with human stratum corneum and its effect on transdermal transport. J Control Release 1997; 45: 131-40. (Pubitemid 27065215)
35. Walde P, Giuliani AM, Boicelli CA, Luisi PL. Phospholipid-based reverse micelles. Chem. Phys. Lipids 1990; 53: 265-88. (Pubitemid 20101162)
36. Abraham W, Downing DT. Interaction between corneocytes and stratum corneum lipid liposomes in vitro. Biochim Biophys Acta 1990; 1021: 119-25. (Pubitemid 20037559)
37. Bhatia A, Kumar R, Katare OP. Tamoxifen entrapped topical liposomes: Development, characterization and in-vitro evaluation. J Pharm Pharm Sci 2004; 7: 252-59. (Pubitemid 41528899)